Search results
Jump to navigation
Jump to search
- ...very high affinity to the [[Imidazoline receptor|I<sub>2</sub> imidazoline receptor]] (K<sub>i</sub> = 40 pM).<ref name="pmid8828003">{{cite journal | vau {{Imidazoline receptor modulators}} ...7 KB (880 words) - 08:15, 28 March 2025
- ...t]] and also has high [[affinity (pharmacology)|affinity]] for the [[sigma receptor]], possibly playing a role in its atypical neuroleptic action.<ref name="pm {{Dopamine receptor modulators}} ...5 KB (642 words) - 03:44, 14 January 2025
- ! Receptor !! K<sub>i</sub> (nM) !! Notes | [[5-HT1A receptor|5-HT<sub>1A</sub>]] || 17.3 || ...7 KB (901 words) - 23:51, 17 June 2025
- {{Adrenergic receptor modulators}} {{Dopamine receptor modulators}} ...7 KB (883 words) - 19:32, 8 September 2024
- ...ethylation of [[dextromethorphan]] by [[CYP2D6]]. Dextrorphan is an [[NMDA receptor antagonist|NMDA antagonist]] and contributes to the psychoactive effects of ...url = https://pdsp.unc.edu/databases/pdsp.php?knowID=0&kiKey=&receptorDD=&receptor=&speciesDD=&species=&sourcesDD=&source=&hotLigandDD=&hotLigand=&testLigandD ...11 KB (1,325 words) - 04:03, 23 January 2025
- {{Monoamine metabolism modulators}} {{Sigma receptor modulators}} ...7 KB (840 words) - 21:27, 30 March 2025
- ...}}</ref> (±)-18-MC competitively inhibits α9α10 [[nicotinic acetylcholine receptor|nAChRs]] with potencies higher than that at α3β4 and α4β2 nAChRs and direct ...se compounds were also found to act as selective [[ganglion type nicotinic receptor|α<sub>3</sub>β<sub>4</sub> nicotinic acetylcholine antagonists]], with litt ...12 KB (1,441 words) - 02:55, 23 June 2025
- ...cts.<ref>{{Cite journal |last=Cott |first=J. M. |date=1997 |title=In vitro receptor binding and enzyme inhibition by Hypericum perforatum extract |url=https:// {{Glutamate receptor modulators}} ...6 KB (765 words) - 11:24, 17 June 2025
- ...ceptor|D<sub>4</sub> receptors]] and the [[5-HT7 receptor|5-HT<sub>7</sub> receptor]]. It is also a [[hERG]] [[channel blocker|blocker]]. ...has a high affinity for the [[Dopamine D2 receptor|dopamine D<sub>2</sub> receptor]] and this likely results in its sexual (due to [[Hyperprolactinaemia|prola ...16 KB (1,975 words) - 05:50, 7 April 2025
- ...lic]]; [[Hallucinogen]]; [[Serotonin]] [[5-HT2A receptor|5-HT<sub>2A</sub> receptor]] [[agonist]] | [[5-HT1A receptor|5-HT<sub>1A</sub>]] || 1,678–>5,600 ...21 KB (2,522 words) - 03:16, 8 June 2025
- | [[5-HT1A receptor|5-HT<sub>1A</sub>]] || 200–270 || Human | [[5-HT1B receptor|5-HT<sub>1B</sub>]] || 1415 || Human ...18 KB (2,268 words) - 21:26, 18 May 2025
- ...tam]] and [[nebracetam]] show some affinity for [[muscarinic acetylcholine receptor]]s, only [[nefiracetam]] demonstrates nanomolar interactions with neurotran ...H, Oswald RE | title = Piracetam defines a new binding site for allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) recepto ...17 KB (2,090 words) - 02:38, 22 April 2025
- | [[5-HT1A receptor|5-HT<sub>1A</sub>]] || >10,000 | [[5-HT1B receptor|5-HT<sub>1B</sub>]] || >10,000 ...20 KB (2,383 words) - 23:08, 17 June 2025
- | Name = ERG2/Sigma-1 receptor |Name=Sigma intracellular receptor 2 ...17 KB (2,088 words) - 20:42, 25 June 2025
- | class = [[Serotonin]]; [[5-HT2 receptor|5-HT<sub>2</sub> receptor]] [[agonist]]; [[Serotonergic psychedelic]]; [[Hallucinogen]] ...rnal | vauthors = Luethi D, Liechti ME | title = Monoamine Transporter and Receptor Interaction Profiles in Vitro Predict Reported Human Doses of Novel Psychoa ...17 KB (2,208 words) - 00:39, 21 June 2025
- | class = [[Serotonin receptor agonist]]; [[Serotonergic psychedelic]]; [[Hallucinogen]] ...rnal | vauthors = Luethi D, Liechti ME | title = Monoamine Transporter and Receptor Interaction Profiles in Vitro Predict Reported Human Doses of Novel Psychoa ...19 KB (2,415 words) - 23:57, 9 May 2025
- | class = [[Serotonin]]; [[5-HT2 receptor|5-HT<sub>2</sub> receptor]] [[agonist]]; [[Serotonergic psychedelic]]; [[Hallucinogen]] | [[5-HT1A receptor|5-HT<sub>1A</sub>]] || 470–916 ...18 KB (2,382 words) - 19:49, 29 May 2025
- | class = [[Serotonin]] [[5-HT2 receptor|5-HT<sub>2</sub> receptor]] [[agonist]]; [[Serotonergic psychedelic]]; [[Hallucinogen]] | [[5-HT1A receptor|5-HT<sub>1A</sub>]] || 190–740 (K<sub>i</sub>)<br />>10,000 ({{Abbrlink|EC< ...21 KB (2,745 words) - 19:49, 29 May 2025
- ...in]]. Pergolide acts on many of the same receptors as dopamine to increase receptor activity. ...JM | title = Safety Pharmacology assessment of drugs with biased 5-HT(2B) receptor agonism mediating cardiac valvulopathy | journal = Journal of Pharmacologic ...20 KB (2,554 words) - 15:24, 21 June 2025
- ...url = https://pdsp.unc.edu/databases/pdsp.php?knowID=0&kiKey=&receptorDD=&receptor=&speciesDD=&species=&sourcesDD=&source=&hotLigandDD=&hotLigand=&testLigandD | [[5-HT1A receptor|5-HT<sub>1A</sub>]] || 145–2829 || {{abbr|ND|No data}} || <ref name="PDSP" ...19 KB (2,517 words) - 13:06, 13 April 2025